| 1 |
中国医师协会急诊医师分会，中华医学会心血管病学分会，中华医学会检验医学分会．急性冠脉综合症急诊快速诊疗指南[J]．中华急诊医学杂志，2016，25(4):397-404.
|
| 2 |
Mozaffarian D，Benjamin EJ，Go AS，et al.Heart disease and stroke statistics--2015 update: a report from the American Heart Association[J]．Circulation，2015，131(4):e29-e322.
|
| 3 |
吴素华，马虹．急性冠脉综合征[M]．广州：广东科技出版社，2007：1-602.
|
| 4 |
Vupputuri A，Sekhar S, Krishnan S，et al.Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain[J]．Indian Heart J，2015，67(6):538-542.
|
| 5 |
Inoue K，Suwa S，Ohta H，et al.Heart fatty acid- binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain[J]．Circ J，2011，75(12):2813-2820.
|
| 6 |
Kim KS，Lee HJ，Kim K，et al.Heart-type fatty acid binding protein as an adjunct to cardiac troponin-I for the diagnosis of myocardial infarction[J]．J Korean Med Sci，2011，26(1):47-52.
|
| 7 |
Lippi G，Mattiuzzi C，Cervellin G．Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction[J]．Clin Biochem，2013，46(1-2):26-30.
|
| 8 |
Ozdemir L，Elonu OH，Gocmen AY.Heart type fatty acid binding protein is more sensitive than troponin I and creatine kinase myocardial band at early stage in determining myocardial injury caused by percutaneous coronary intervention[J]．Int Heart J，2011，52(3):143-145.
|
| 9 |
Chen L，Guo X，Yang F．Role of heart-type fatty acid binding protein in early detection of acute myocardial infarction in comparison with cTnI，CK-MB and myoglobin[J]．J Huazhong Univ Sci Technolog Med Sci，2004，24(5):449-451,459.
|
| 10 |
Gururajan P，Gurumurthy P，Nayar P，et al.Heart fatty acid binding protein (H-FABP) as a diagnostic biomarker in patients with acute coronary syndrome[J]．Heart Lung Circ，2010，19(11):660-664.
|
| 11 |
Meuwese MC，Stroes ES，Hazen SL，et al.Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals[J]．J Am Coll Cardiol，2007，50(2):159-165.
|
| 12 |
Baldus S，Heeschen C，Meinertz T，et al.Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes[J]．Circulation，2003，108(12):1440-1445.
|
| 13 |
Nicholls SJ，Hazen SL.Myeloperoxidase and cardiovascular disease[J]．Arterioscler Thromb Vasc Biol，2005，25(6):1102-1111.
|
| 14 |
Daugherty A，Dunn JL，Rateri DL，et al.Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions[J]．J Clin Invest，1994，94(1):437-444.
|
| 15 |
Brennan ML，Penn MS，Van Lente F，et al.Prognostic value of myeloperoxidase in patients with chest pain[J]．N Engl J Med，2003，349(17):1595-1604.
|
| 16 |
Nicholls SJ，Tang WH，Brennan D，et al.Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain[J]．Clin Chem.2011，57(12):1762-1770.
|
| 17 |
Karadag B，Vatan B，Hacioglu Y，et al.Serum myeloperoxidase level predicts reperfusion in patients with myocardial infarction receiving thrombolytic therapy[J]．Heart Vessels，2009，24(4):247-253.
|
| 18 |
Wong ND，Gransar H，Narula J，et al.Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events[J]．JACC Cardiovasc Imaging，2009，2(9):1093-1099.
|
| 19 |
Tang W，Wu Y，Nicholls S，et al.Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease[J]．Clin Chem，2011，57(1):33-39.
|
| 20 |
Brennan ML，Penn MS，Van Lente F，et al.Prognostic value of Myeloperoxidase in patients with chest pain[J]．N Engl J Med，2003，349(17):1595-1604.
|
| 21 |
Zhang QM, Ren CM. Myocardial enzymes and cardiactroponintesting retrospective analysis[J]. J Pract Med，2011，27(5):769.
|
| 22 |
Mehta MD，Marwah SA，Ghosh S，et al.A Synergistic role of myeloperoxidase and high sensitivity troponin t in the early diagnosi[J]．Indian J Clin Biochem，2016，31(1):75-80.
|
| 23 |
Sawicki M，Sypniewska G，Kozinski M，et al.Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes[J]．Eur J Clin Invest，2011，41(6):667-671.
|
| 24 |
Goldmann BU，Rudolph V，Rudolph TK，et al.Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction[J]．Free Radic Biol Med，2009，47(1):79-83.
|
| 25 |
Pyati AK，Devaranavadagi BB，Sajjannar SL，et al.Heart-type fatty acid binding protein：a better cardiac biomarker than CK-MB and myoglobin in the early diagnosis of acute myocardial infarction[J]．J Clin Diagn Res，2015，9(10):BC08-11.
|
| 26 |
郑伯仁，陈烨，马国斌．心肌肌钙蛋白I诊断急性心肌梗塞的意义[J]．心血管康复医学杂志，1999，8(3):69-70.
|
| 27 |
吴建榕，马奕晶，马春梅．建立北京健康人血浆髓过氧化物酶参考值和氧化低密度脂蛋白、脂蛋白磷脂酶参考区间[J]．中华临床实验室管理电子杂志，2016，4(2):116-121.
|
| 28 |
李洁琪，李晓翔，吴立荣．心脏型脂肪酸结合蛋白在不稳定性心绞痛患者危险分层诊断中的价值[J]．山东医药，2009，49(9):1-2.
|
| 29 |
Nakata T，Hashimoto A，Hase M，et al.Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome[J]．Cardiology，2003，99(2):96-104.
|
| 30 |
伏长青，朱晓珏，曹晖．人髓过氧化物酶和心脏脂肪酸结合蛋白在急性心肌梗死诊断中的意义[J]．临床输血与检验，2015，17(6):501-503.
|
| 31 |
Kacprzak M，Zielinska M．Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention[J]. Int J Cardiol，2016，223:452-457.
|
| 32 |
Kilcullen N，Viswanathan K，Das R，et al.Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values[J]．J Am Coll Cardiol，2007，50(21):2061-2067.
|
| 33 |
Niizeki T，Takeishi Y，Arimoto T，et al.Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients[J]．J Card Fail，2007，13(2):120-127.
|
| 34 |
Omran MM，Zahran FM，Kadry M，et al.Role of myeloperoxidase in early diagnosis of acute myocardial infarction in patients admitted with chest pain[J]．J Immunoassay Immunochem，2018，39(3):337-347.
|
| 35 |
Maznyczka A，Kaier T，Marber M．Troponins and other biomarkers in the early diagnosis of acute myocardial [J]．Postgrad Med J，2015，91(1076):322-330.
|
| 36 |
丛玉隆，陈文祥，高尚先，等．临床检验装备大全：试剂与耗材(第3卷下册)[M]．北京：科学出版社，2016：1220-1223，1230-1232.
|
| 37 |
贾克刚，刘军辉，马明坤，等．血清髓过氧化物酶和高敏C反应蛋白与冠状动脉粥样硬化的相关性研究[J]．检验医学，2007，22(2):179-181.
|
| 38 |
金顺喜．血清髓过氧化物酶检测方法的建立及其在冠心病危险分层及预测急性冠脉事件的应用研究[J]．现代诊断与治疗，2013，24(8):1733-1734.
|
| 39 |
王慧洁，丁世芳．髓过氧化物酶与急性冠脉综合征的关系[J]．中国动脉硬化杂志，2013，21(10):955-960.
|
| 40 |
刘瑶，田亚平，艾珺平. 髓过氧化物酶对急性冠状动脉综合征早期识别和急性心肌梗死诊断的价值[J]．解放军医学院学报，2014，35(6):533-537.
|
| 41 |
Ishii J，Ozaki Y，Lu J，et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome[J]．Clin Chem，2005，51(8):1397-1404.
|
| 42 |
Viswanathan K，Kilcullen N，Morrell C，et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative[J]．J Am Coll Cardiol，2010，55(23):2590-2598.
|
| 43 |
Chen Y，Zhang F，Dong L，et al. Long-term prognostic value of myeloperoxidase on acute coponary syndrome：a meta-analysis[J]．Arch Med Res，2011，42(5):368-374.
|
| 44 |
黄山，邓小林．心脏标志物实验室检测应用指南[M]. 北京：中国科学技术出版社，2015：82-177.
|
| 45 |
高小文，孙安平，陈建华，等．抗凝剂对髓过氧化物酶检测结果影响的分析[J]．标记免疫分析与临床，2014，21(4):458-461.
|
| 46 |
高小文，孙安平，陈建华，等．不同的标本保存条件，溶血情况对髓过氧化物酶检测的影响[J]．标记免疫分析与临床，2014，21(4):435-438.
|
| 47 |
Krahn J，Parry DM，Leroux M，et al.High percentage of false positive cardiac troponin I results in patients with rheumatoid factor[J]．Clin Biochem，1999，6(32):477-480.
|
| 48 |
Onuska KD，Hill SA. Effect of rheumatoid factor on cardiac troponin I measurement using two commercial measurement systems[J]．Clin Chem，2000，46(2):307-308.
|
| 49 |
Gerhardt W，Nordin G，Herbert AK，et al.Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury[J]．Clin Chem，2000，46(6):817-821.
|
| 50 |
王大海，李特，程熠，等．髓过氧化物酶与动脉粥样硬化的研究进展[J]．中国老年学杂志，2013，33(7):1722-4
|
| 51 |
王小平，马达，王万相，等．脂肪酸结合蛋白对急性心肌梗死早期诊断中的价值[J]．中华急诊医学杂志，2001，10(5):337- 338.
|
| 52 |
Abbasi WA，Saleem M，Rasheed S，et al.Utility of heart type fatty acid binding protein (h-fabp) point of care test in the early hours of stemi compared with troponin-i in pakistani population[J]．J Ayub Med Coll Abbottabad，2017，29(1):107-111.
|
| 53 |
袁洁，黄荫浩，魏美芳．急性冠脉综合征患者心肌脂肪酸结合蛋白检测的意义[J]．交通医学，2007，21(6):663-663.
|
| 54 |
谢兆弟，武强，黄键，等．急性冠脉综合征患者血清髓过氧化物酶含量检测对病情评估的价值[J]．海南医学院学报，2017，23(1):34-37.
|
| 55 |
刘海波，郭小芳，张丽梅，等．心肌脂肪酸结合蛋白浓度对急性冠脉综合征临床转归的预测价值[J]．中国病理生理杂志，2011，27(2):238-242 .
|
| 56 |
盛臻强，卢辉和，王毅，等 .hsCRP 、H-FABP检测对不稳定型心绞痛患者近期预后的预测价值[J]．山东医药，2007，47(34):36-37 .
|
| 57 |
Casals G，Filella X，Bedini JL.Evaluation of a new ultrasensitive assay for cardiac troponin I[J]．Clin Biochem，2007，40(18):1406-1413.
|
| 58 |
Kavsak PA，MacRae AR，Yerna MJ，et al.Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury[J]．Clin Chem，2009，55(3):573-577.
|